This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Meet Teresa Cooper, Ph.D.

Principal, Deloitte Consulting LLP
Chief Inclusion Officer
National Leader, Life Sciences R&D Practice

Dr. Cooper is a Principal of Deloitte Consulting and is Consulting’s chief inclusion leader with responsibility for the practice’s Women's Initiative (WIN), diversity and flexibility initiatives as well as the National Leader of the Life Sciences R&D practice. She has two decades of experience working in various capacities relating to the pharmaceutical industry. For the past 13 years she has worked as a consultant to the industry. Prior to joining Deloitte Consulting LLP she was a partner in the Global Pharmaceutical/Life Sciences Practice within IBM Business Consulting practices, where she had responsibility for leading the Global R&D Pharmaceutical/Life Sciences practice. In her current client relationship role, she has responsibility for the research and development related services being provided to certain global pharmaceutical companies headquartered in the U.S.

In her career as a consultant, Dr. Cooper has participated in a broad range of strategic advisory services for pharmaceutical companies. Activities supported include the creation of global business models; the integration of development, regulatory and drug safety functions in a number of pharmaceutical mergers; the restructuring of global marketing while facilitating a product launch; the restructuring of regulatory affairs; the reengineering of the regulatory and clinical components of a product development process; and the reengineering of information management processes.

Prior to becoming a consultant, Dr. Cooper worked for eight years within the pharmaceutical industry. Her background spanned clinical development, regulatory affairs, sales and marketing. She gained a broad range of experience in developing new products and obtaining product licenses in the U.K. and the U.S. She also contributed to the launching of a major new pharmaceutical brand while also maintaining the growth of older existing products in competitive therapeutic markets while she was with Janssen Pharmaceuticals Ltd.

Dr. Cooper is a frequent participant at industry conferences where she frequently speaks on topics relating to the issues affecting pharmaceutical research and development.

She holds a Joint Honours Bachelor of Science Degree in Chemistry and Pharmacology and a Ph.D. in Pharmacology from the University of London, U.K.

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Related links

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected